GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) » Definitions » EV-to-Revenue

Torrent Pharmaceuticals (NSE:TORNTPHARM) EV-to-Revenue : 8.87 (As of May. 12, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Torrent Pharmaceuticals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Torrent Pharmaceuticals's enterprise value is ₹915,374 Mil. Torrent Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹103,187 Mil. Therefore, Torrent Pharmaceuticals's EV-to-Revenue for today is 8.87.

The historical rank and industry rank for Torrent Pharmaceuticals's EV-to-Revenue or its related term are showing as below:

NSE:TORNTPHARM' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.02   Med: 4.54   Max: 8.96
Current: 8.87

During the past 13 years, the highest EV-to-Revenue of Torrent Pharmaceuticals was 8.96. The lowest was 2.02. And the median was 4.54.

NSE:TORNTPHARM's EV-to-Revenue is ranked worse than
86.27% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 2.41 vs NSE:TORNTPHARM: 8.87

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-12), Torrent Pharmaceuticals's stock price is ₹2599.90. Torrent Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹304.97. Therefore, Torrent Pharmaceuticals's PS Ratio for today is 8.53.


Torrent Pharmaceuticals EV-to-Revenue Historical Data

The historical data trend for Torrent Pharmaceuticals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Torrent Pharmaceuticals EV-to-Revenue Chart

Torrent Pharmaceuticals Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.07 4.95 5.99 6.03 5.99

Torrent Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.76 5.99 6.63 6.82 7.56

Competitive Comparison of Torrent Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Torrent Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Torrent Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Torrent Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Torrent Pharmaceuticals's EV-to-Revenue falls into.



Torrent Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Torrent Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=915374.299/103186.9
=8.87

Torrent Pharmaceuticals's current Enterprise Value is ₹915,374 Mil.
Torrent Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹103,187 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Torrent Pharmaceuticals  (NSE:TORNTPHARM) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Torrent Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2599.90/304.968
=8.53

Torrent Pharmaceuticals's share price for today is ₹2599.90.
Torrent Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹304.97.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Torrent Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Torrent Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Torrent Pharmaceuticals (NSE:TORNTPHARM) Business Description

Traded in Other Exchanges
Address
Off Ashram Road, Torrent House, Ahmedabad, GJ, IND, 380009
Torrent Pharmaceuticals Ltd is a drug manufacturing company with a focus on the cardiovascular, central nervous system, and gastrointestinal therapeutic areas. It operates through Generic Formulation Business segments. Geographically, the business activities are carried out across Indian and International markets.

Torrent Pharmaceuticals (NSE:TORNTPHARM) Headlines

No Headlines